We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CYTX market cap is 939.43k. The company's latest EPS is USD -2.9441 and P/E is -0.62.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 73k | 151k | 506k | 1.85M | 1.24M |
Operating Income | -5.09M | -5.57M | -4.72M | -1.49M | -3.25M |
Net Income | -5.22M | -5.66M | -4.81M | -1.48M | -3.22M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 7M | 303k | 0 | 224k | 4.91M |
Operating Income | -3.66M | -9.58M | -12.43M | -19.71M | -13.32M |
Net Income | -11.44M | -8.24M | -13.4M | -20.28M | -13.32M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 23.1M | 23.87M | 15.64M | 14.2M | 13.28M |
Total Liabilities | 11.7M | 17.42M | 12.96M | 11.54M | 10.66M |
Total Equity | 11.4M | 6.45M | 2.68M | 2.66M | 2.62M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 23.23M | 12.11M | 21.98M | 23.87M | 11.39M |
Total Liabilities | 22.07M | 9.07M | 11.15M | 17.42M | 12.74M |
Total Equity | 1.16M | 3.03M | 10.84M | 6.45M | -1.35M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -10.74M | -12.97M | -5.79M | -8.57M | -10.97M |
Investing | -748k | -759k | -97k | -108k | -118k |
Financing | 13.35M | 13.45M | 493k | 1.45M | 3.97M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -5.91M | -8.43M | -10.28M | -12.97M | -12.85M |
Investing | 5.57M | -493k | -82k | -759k | -160k |
Financing | 12.63M | -319k | 20.42M | 13.45M | 3.45M |
Market Cap | 939.43k |
Price to Earnings Ratio | -0.62 |
Price to Sales Ratio | 1.69 |
Price to Cash Ratio | 0.97 |
Price to Book Ratio | -6.17 |
Dividend Yield | - |
Shares Outstanding | 4.52M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0.48%) |
Company Name | Cytori Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://plustherapeutics.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions